ABSTRACT Background: Case-control designs are commonly employed in genetic association studies. In addition to the case-control status, data on secondary traits are often collected. Directly regressing secondary traits on genetic variants from a case-control sample often leads to biased estimation. Several statistical methods have been proposed to address this issue. The Inverse-Probability-Weighting (IPW) approach and the semi-parametric maximum likelihood (SPML) approach are the most commonly used. Methods: A new weighted estimating equation (WEE) approach is proposed to provide unbiased estimation of genetic associations with secondary traits, by combining observed and counter-factual outcomes. Compared to the existing approaches, WEE is more robust against biased sampling and disease model mis-specification. Simulations: We conducted simulations to evaluate the performance of WEE under various models and sampling schemes. WEE demonstrated robustness in all scenarios investigated, had appropriate type I error, and was as powerful or more powerful than IPW and SPML approaches. Applications: We applied WEE to an asthma case-control study to estimate the association between the thymic stromal lymphopoietin gene and two secondary traits: overweight status and serum IgE level. WEE identified two SNPs associated with overweight in logistic regression, and three SNPs associated with serum IgE levels in linear regression, and an additional four SNPs that were missed in linear regression to be associated with the 75th quantile of IgE in quantile regression. Conclusion: WEE approach provides a general and robust secondary analysis framework, which complements the existing approaches and should serve as a valuable tool for identifying new associations with secondary traits.
More sophisticated methods aiming to avoid the aforementioned bias can be broadly classified into two groups. The first group is based on the inverse probability weighting (IPW) idea which is widely used in survey methodology. Jiang et al. (2006) , Richardson et al. (2007) and Monsees et al. (2009) introduced the IPW approach to genetic studies when case and control sampling probabilities are available. The main idea of IPW is to re-weight individual observations by the inverse of their selection probabilities and conduct weighted regressions. This approach requires the information of the case-control sampling scheme to construct the weights, and is often biased or inefficient when there are unobserved confounders and over-weighted sub-samples.
The second group explicitly accounts for the case-control sampling scheme by maximizing the retrospective likelihood function conditional on the primary disease or joint modeling of the primary and secondary traits (Jiang et al. 2006; Lin and Zeng 2009; He et al. 2011; Shete 2011, 2012; Li and Gail 2012; Wei et al. 2013; Ghosh et al. 2013) . The semi-parametric maximum likelihood (SPML) proposed by Lin and Zeng (2009) is the most widely recognized approach in this group as it largely improves the efficiency over IPW. This approach makes the linear logit assumption for the probability of primary disease with respect to genotypic score and secondary trait. This approach is very sensitive to its assumption and can be largely biased when it is violated. Li and Gail (2012) proposed an adaptive weighted approach aiming at improving the robustness of SPML by weighting the estimates from SPML and its extension (including the interactive effects of genetic markers and secondary trait in predicting case-control status in its assumption). However, the efficiency was lost and simulations showed that its biases can be as large as 46% (Wang and Shete 2012) . He et al. (2011) ; Shete (2011, 2012) ; Wei et al. (2013) and Ghosh et al. (2013) approached this issue from different perspectives, but they were all based on a similar model specification of primary disease, and their estimation efficiency over SPML was marginal. Therefore, for the comparison presented in this paper, we focus our work mainly on the IPW and SPML approaches.
Despite of the tremendous efforts on secondary analysis, there are a number of remaining issues. First, the performance of existing methods heavily depends on either the sampling scheme or the correct specification of the primary disease model. Since many case-control studies of complex diseases do not have clear selection probabilities and distribution of primary disease, the estimations from these existing methods can be biased. Second, for the novel approaches that are likelihood based, additional challenges arise for regressions with no parametric likelihood functions. For example, the FTO genotype is not only associated with the mean but also with the variance of BMI (Frayling et al. 2007) . Instead of considering only the mean of phenotypes in GWAS, it is valuable to systematically examine how the markers influence the location, scale, and shape of the entire trait distribution through quantile regression (Koenker and Bassett Jr 1978) . Such quantile regressions can identify additional markers missed by mean regressions that are associated with certain quantiles of the trait. Existing secondary analysis approaches are not developed to facilitate these types of regressions, and the expansion from likelihood based secondary approaches is especially difficult.
In this paper, we propose a set of weighted estimating equation (WEE) approaches, providing unbiased estimation for the secondary analysis in genetic case-control studies. We introduce a new concept of counter-factual estimating functions under alternative disease status, and combine the observed and counterfactual estimating functions into a set of weighted estimating equations. The counter-factual outcomes idea has been widely used in causal inference to denote the potential outcomes of the subjects if they were in the alternative treatment or exposure group, and conclusions are made if the actual and counterfactual outcomes from the same subjects differ. Here, we borrow this idea to define the potential secondary trait of the subjects if they were in the alternative case-control status, and estimate the marker-secondary trait association using the case-control sample. In comparison with the existing approaches, it provides a very generalizable and robust regression framework in analyzing secondary phenotypes with limited information on the sampling scheme and the underlying primary disease models. It is flexible to handle various types of secondary phenotypes regardless of their relationship with the primary disease. After first considering WEE for quantile regression in Wei et al. (2015) , we expand this idea to a more general framework that accommodates a wide range of regressions. This work is outlined in this paper, which is structured as follows. We first introduce the construction of WEE approach. Second, we present the simulations that investigate the finite sample performance under different scenarios. Finally, we consider a real data example of an asthma case-control study with one binary secondary trait (overweight status) and one continuous secondary trait (serum Immunoglobulin E (IgE) levels) to illustrate our approach.
Proposed Method

Notations and settings
Let X denote the coded genotype for a variant of interest, Y denote a secondary phenotype, Z denote the vector of covariates to adjusted for, and D={0, 1} denote the primary disease status. The aim of the secondary trait analysis is to estimate the genetic effect of X onto Y in the general population. The relation between Y and X and Z can be modeled as follows:
where g(·) is a link function, and β 1 is the coefficient of primary interest. Depending on the choice of g, model (1) covers a wide range of regressions. For example, if
is the quantile function at the τth quantile for Y, then it is quantile regression. In a case-control design, the data at a single variant consists of n 1 cases {x i , z i , y i , d i = 1}, i = 1, 2, ..., n 1 , and n 0 controls {x i , z i , y i , d i = 0}, i = n 1 + 1, n 1 + 2, ..., n 1 + n 0 . We denote by n = n 1 + n 0 the total sample size. When the secondary phenotype Y is associated with the primary disease D, directly regressing Y against X using case-control samples leads to biased estimation of β 1 . Therefore, we propose a weighted estimating equation based approach for secondary trait analyses in casecontrol studies. It utilizes the entire case-control sample, and yields consistent estimation of β 1 in the general population.
Weighted estimating equations for the secondary phenotypes in genetic case-control studies
Constructing estimating equations is a common estimation method. The key is to find an estimating function S(X, Y, Z, β) such that for randomly selected subjects from the general popu-lation, the following equations hold at the true β * ,
In generalized linear models (GLM), the estimating function S(X, Y, Z, β) can be constructed as the first derivative of loglikelihood function, which is known as Fisher's score function. In other regressions that minimize certain loss functions, S(X, Y, Z, β) is the first derivative of the corresponding loss function. For example, the estimating function with respect to β 1 is
at any quantile τ ∈ (0, 1) in quantile regression. As we do not have a representative sample of the population, solving equation (2) directly in a case-control sample is biased. However, conditioning on the disease status D, we can expand the above equation as follows,
This expansion provides the basis of constructing the proposed weighted estimating equations. Suppose that for each y i in the sample, we are able to observe its counter-factual secondary outcomesỹ i under the alternative disease status. Specifically, y i would be the phenotype of the ith case if it is in fact a control, andỹ i would be the phenotype of the ith control if it is actually a case. If we are able to observe both y i andỹ i 's, we can then construct the unbiased estimating equations following the expanded estimating equation (3). The sample estimation equations can be written as follows:
where the weight p(d i |x i , z i ) is the probability of being the observed disease status given (x i , z i ), and p(1 − d i |x i , z i ) is the probability of being the counter-factual disease status. The optimization of estimating equations (4) (2000)), solving equation (4), S n (β) = 0, leads to the consistent estimation of β as S n (β) is a consistent estimation function as long as y i is a random sample conditioning on (d i , x i , z i ). In IPW, the coefficients can be unbiasedly estimated only when y i given d i is a random sample. Therefore, the proposed approach is less sensitive to the sampling scheme than IPW approach. Although the estimating equations involve P(D|X, Z), we are not assuming the disease probability only relates to (X, Z). In reality, the disease risk can relate to Y or other auxiliary variables W as well, and p(D|X, Z) in equation (4) can be viewed as the marginal probability given (X, Z), i.e. p(D|X, Z) = y,w p(D|X, Z, y, w)dF (y,w) (y, w), where F (y,w) is the joint distribution of (y, w).
Of course in practice we are unable to observe the counterfactual secondary outcomes. To get around this difficulty, we propose two approaches. The first one is to estimate the expectation of counter-factual estimating functions. When S(x i , y i , z i , β) is linear in y i , we recommend to replace S(x i ,ỹ i , z i , β) by its conditional expectation overỹ i . In general for non-linear estimation functions, we propose to generate pseudo observations from two sets of stratified models. In the next two subsections, we elaborate on the two approaches under the assumption that the probability p(d i |x i , z i ) is known, and an algorithm to estimate p(d i |x i , z i ) is followed.
Estimation approach A: estimating the expected counterfactual estimating function
One can easily show that the following estimating equations, which substitute S(x i ,ỹ i , z i , β) by its conditional expectation, are unbiased as well.
When the estimating function S(x i ,ỹ i , z i , β) is linear inỹ i , this approach is particularly appealing since one can simply replacẽ y i by its conditional mean. In this case, the estimation equations (5) are equivalent to
The conditional means E(ỹ i |x i , z i ) can be easily estimated from stratified linear regression. Specifically, one can regress y i against x i and z i separately among cases and controls, and estimate E(ỹ i |x i , z i ) by the predicted value under alternative disease status model. This way, the estimate can be obtained using one-step optimization, by solving the following equations:
where E(ỹ i |x i , z i ) is the predicted outcome given x i and z i under the alternative disease status.
Estimating equations (5) remain unbiased when S(
in such case could be computationally undesirable, especially when the model is high-dimensional. We hence propose an alternative approach that is flexible and computationally efficient.
Estimation approach B: generating pseudo counter-factual observations
Under model (1), the linear association between Y and (X, Z) holds among both cases and controls. The regression coefficients, however, can vary between them. Therefore, we propose to fit model (1) separately for cases and controls, and use the resulting stratified models to generate pseudo counter-factual observations. Here, we consider two scenarios to illustrate this idea. One is GLM and the other is quantile function.
Simulating counter-factual outcomes in GLM
is the stratified estimated models for cases and controls, where d = 1 for cases and d = 0 for controls. For each observation i, we generate its counter-factual outcome from the estimated model of the alternative disease status g 1−d . Specifically, if g is a logit link for binary secondary trait, then ỹ i is a random draw from a Bernoulli distribution with success probability
If g is a log link for count secondary trait, then ỹ i is a random draw from a Possion distribution with λ i = exp{ g 1−d (y i )}.
Simulating counter-factual outcomes in quantile regression
Since quantile regression does not have full parametric likelihood functions, one needs to consider the main model (1) across the entire distribution of Y to simulate counter-factual phenotypes. This joint modeling approach for quantile regression has been described in Wei et al. (2006) , and the quantile based counter-factual outcome generations have been described in details in Wei et al. (2015) . Here, we summarize how we have been able to generate counter-factual outcomes based on a grid of evenly spaced quantiles. We let 0 < τ 1 < τ 2 < · · · < τ k < 1 denote a set of k evenly spaced quantile levels, and β
) denote the quantile coefficient functions given disease status D=d such that
for any τ ∈ (0, 1). Then y i is simulated following the modelestimated conditional distribution of y i given (x i , z i ) and d i as follows:
1. We estimate the quantile coefficients for β(τ k | d) in equation (8) within cases and controls, respectively.
2. To approximate the coefficient process β
and is subject to the constraint of
3. We randomly draw the quantile level u i from Uniform (0, 1) distribution and simulate the pseudo outcome y i by y i =
Stabilizing the coefficients
With ỹ i , we construct the sampling estimating equations as
(9) As simulating the pseudo counter-factual outcome might introduce variation for small samples, we propose to repeat the procedure above T times to obtain stable estimates. The final estimate is the average of the T estimates, i.e.
where β (t) is the estimated coefficient from the t-th set of pseudo outcomes. In our numerical studies, we used T from 1 to 100, and found that the variance of the estimates stabilizes fairly quickly after T = 10.
For the two estimation algorithms described above, we assumed that the conditional disease probability p(d i |x i , z i ) was known. In practice, it needs to be estimated. To estimate p(d i |x i , z i ), we could use the models from primary analysis or simply assume a logistic model
We can achieve a consistent estimation of the slope parameters γ 1 and γ 2 by conducting logistic regression in the case-control sample. The intercept γ 0 needs to be calibrated to match the overall disease prevalence in the general population. Let P 0 denote the known disease prevalence, then we can estimate γ 0 by solving the following equation:
where F XZ is the joint distribution of X and Z, and γ 1 and γ 2 are the estimated γ 1 and γ 2 from logistic regression. The joint distribution F XZ can be estimated using population databases. If difficult to obtain, we propose a sample version to approximate γ 0 as follows:
When the disease prevalence P 0 or the disease model is misspecified, the resulting estimated coefficients could be slightly biased. The estimation of the coefficients when the P(D|X, Z) is mis-specified in considered in simulations.
Bootstrap procedure for the confidence intervals and hypothesis tests
In previous sections, we have outlined two estimation algorithms to estimate the parameters in model (1). Although the estimates can be viewed as some form of weighted regressions, the direct output of the Wald test statistics does not take into account the uncertainty from the estimated p(d|x, z) and simulated ỹ i . Therefore, we propose to use a bootstrap method to obtain the variance-covariance matrices of our proposed estimates. With the bootstrap standard errors, we are able to construct bootstrap confidence intervals and apply Wald test statistics to test the null hypothesis H 0 : β 1 = 0, i.e. whether the genetic variant(s) are associated with the secondary phenotype Y in the general population. The bootstrap procedure is as follows: 1. Bootstrap cases and controls separately to assemble a bootstrap case-control sample. Namely we randomly select n 1 cases from case sample and n 0 controls from control sample with replacement.
2. For each bootstrap sample, we re-apply the proposed algorithm to obtain bootstrap estimates. For approach A, it includes re-estimating Eỹ i [S(x i ,ỹ i , z i , β)] and p(d|x i , z i ). For approach B, it includes re-generating pseudo-outcomes ỹ i and re-estimating p(d|x i , z i ) .
3. We repeat steps 1 and 2 B times, then calculate the bootstrap standard error. We use the bootstrap standard error to construct confidence intervals and bootstrap Chi-square test statistics for inference.
We evaluated the type I error and power of this bootstrap procedure in simulations and the bootstrap based inferences are applied to the real data examples.
Simulation Results
Finite sample performance
We use simulations to evaluate the performance of the proposed WEE approach, and compare its findings with several commonly used methods. We consider the scenario of a pre-selected SNP with binary and continuous secondary phenotypes in the framework of a case-control study. As quantile regression has been extensively explored in Wei et al. (2015) , here we focus on its performance in parametric regressions (logistic and linear regressions).
Model settings:
As before, we denote that D = {0, 1} is the primary disease status, X = {0, 1, 2} is the genotype information at the SNP (under additive model) with minor allele frequency (MAF) 0.3, and by Z is a covariate of interest following a standard normal distribution. The correlation coefficient between X and Z is 0.3. We consider both binary and continuous secondary phenotypes Y. For binary Y, we assume a logistic model as follows:
For continuous Y, we assume the following linear model
where the error term ε follows N(0, 1). Under the binary secondary phenotype model, the prevalence of Y is approximately 30%. In both models, β * 1 = 0.2 is the true coefficient of X in predicting Y, and is the coefficient of primary interest.
To model the disease probability P(D|X, Y, Z), we consider three possible settings. Setting 1 (Logistic setting) assumes the probability of disease follows a logistic model with main effects of X and Y. Similar settings were considered in Lin and Zeng (2009) and Wang and Shete (2011) . Setting 2 (Interaction setting) extends the Logistic Setting by including the X − Y interaction. Similar settings were considered in Li and Gail (2012) and Wang and Shete (2012) . Finally, Setting 3 (Piecewise setting) assumes that P(D|X, Y, Z) follows piecewise linear model instead of logistic regression. The detailed mathematical forms of the disease models are given below.
• Setting 1 (Logistic setting):
• Setting 2 (Interaction setting):
• Setting 3 (Piecewise setting):
where U 1 and U 2 are the 0.25th and 0.75th quantiles of the 0.3X + log(2)Y + log(2)Z, respectively. In all the disease models above, we assume that the prevalence of the primary disease (P 0 ) is 10%. The intercepts γ 0 in these models are selected to match the overall disease prevalence in the population. For each of the model settings above, we generate a large number of observations (N = 500, 000), which we treat as a general population.
Sampling schemes:
We consider three sampling schemes to select the case-control samples. First, we consider a simple sampling scheme in which cases and controls are randomly drawn into the sample, which creating the selection probability only depends on the disease status. This is the simplest available sampling design, but the collection of data is often difficult, especially when the sample size is large. Second, we consider the convenient sampling schemes to collect data that researchers often encounter in case-control studies. For example, in a stroke GWAS study (Cornelis et al. 2010) , cases were selected from imaging-confirmed cases from seven clinical centers, while controls were selected using existing healthy subjects in an acute myocardial infarction study with similar recruitment criteria. Data under this sampling scheme are easy to collect, but the confounding factors associated with selection probabilities may not be fully captured. We then evaluate the performance of WEE and existing methods in the presence of unmeasured confounders. Finally, we consider the stratified sampling scheme, which is often used in large-scale case-control studies to under or over-sample subjects with certain characteristics. This sampling scheme can largely improve the estimation efficiency for the small subgroups. For example, the National Maternal and Infant Health Survey oversampled the infants born with low birthweight (≤ 2500 g) and very low birthweight (≤1500 g) to study the long-term and short-term health outcomes of these infants. This is a common scenario when IPW fails because certain subjects carrying large weights may dominate the estimates. Specifally, we select 2,000 cases and 2,000 controls into the sample in one of the following ways.
• Setting 1 (Random sample): subjects randomly selected in to the sample. • Setting 2 (Convenience sample): Assume V is an uncaptured variable associated with (X, Y, Z) such that
and only the subjects with V = 1 are selected into the sample. • Setting 3 (Stratified sample): V ∼ N(0, 1) and V ⊥ (X, Y, Z, D). Subjects with V > 0 are 9 times more likely to be selected into the sample than subjects with V < 0.
Comparison methods:
We estimated the coefficients under the random sample of different models above using the following methods : (1) regression using cases only, (2) regression using controls only, (3) regression using combined case-control sample, (4) regression using disease status stratified case-control sample, (5) IPW, (6) SPML, (7) the proposed WEE approach. In IPW approach, we model cases and controls separately, and weights them inversely to their probability of selection
. The estimating equation of IPW is as follows:
For SPML approach, we use the external SPREG software provided by the authors (http://dlin.web.unc.edu/software/spreg-2/).
In WEE approach, we use estimating approach A of taking the conditional expectation of the counter-factual score function in the linear regression, which solves through a simple one-step optimization; we use estimating approach B of generating pseudo observations in logistic regression. We vary the T values from 1 to 100 (T is the number of pseudo samples generated) and compare their estimates. We assume we have no prior knowledge of F XZ and the weight P(D|X, Z) is estimated through the sample version equation (Equation (13)). We then further compare WEE with IPW and SPML approaches in both the convenient and stratified samples. As outlined in the introduction, IPW is the most simple and robust method and SPML is the most efficient and popular method in the current available secondary analysis literature. Table 1 summarizes the relative bias, standard error and mean squared error of the estimated coefficients β 1 based on 500 Monte-Carlo replicates from random samples using all methods. According to the table, the classical methods, including regressions applied to the cases only, controls only, combined case-control sample directly and combined case-control sample adjusting for primary disease status, are all biased. Hence, without appropriate adjustment, classical methods provide biased estimation for the X − Y association in genetic case-control data.
Results and discussions:
The proposed WEE approach performs well in correcting such bias in all the settings we considered. In logistic regression, we generated pseudo counter-factual observations. The estimated coefficients are unbiased even with T = 1. The standard errors do decrease slightly as T increases, but they quickly stabilize after T = 10. Therefore, we conclude that a relatively small number of imputations is enough to reach the optimal efficiency of this approach, and therefore it is computationally efficient. In addition, we assumed the working model as P(D|X, Z) = exp(γ 0 + γ 1 X + γ 2 Z)/(1 + exp(γ 0 + γ 1 X + γ 2 Z)) in estimation, which is not affected by the Y − D associations. It is different from the one used to generate the data; the generating model is based on three P(D|X, Y, Z) settings, including Logistic, Interaction and Piecewise Settings. Even under the misspecified P(D|X, Z), the proposed estimating equation based approach performs fairly well, indicating that it is quite robust to the P(D|X, Z) model mis-specification. Additional scenarios to test the robustness boundary of P(D|X, Z) are described in later sections.
The IPW also produces fairly accurate estimates in all models and demonstrates comparable efficiency in comparison with WEE in Table 1 . The calculation of IPW method, however, requires the information on sampling scheme. Under the random samples, where the selection of cases and controls depends solely on the disease status, it is similar as using the disease prevalence to calculate p(d i |x i , z i ) in WEE. Therefore, it is not surprising to observe comparable performance in this scenario. Table 2 further compares IPW with WEE under complex sampling schemes, and shows that IPW is less robust and efficient than WEE in these scenarios. Under convenient sampling schemes with unadjusted confounding factors, every method contains some biases. The biases are controlled within 7% in WEE, but they can reach up to 25% in IPW. This is because WEE is less affected by the confounding factors as long as Y given (X, Z) is a representative sample of the population. Under the stratified sampling scheme, the IPW estimates suffer from inflated variance, because subjects with large sampling weights dominate the estimates. However, subjects with similar (X, Z) values contribute similar weights in WEE, which therefore is robust to the stratification. We further compare their power under this scenario in the next section.
The SPML approach provides unbiased and relative efficient estimations when the linear logistic model assumption is satisfied but introduces biases when this assumption is violated. Specifically, the SPML estimate is the most efficient of all methods we considered in random samples under the Logistic setting. Under Interaction and Piecewise settings, where the linear logistic model assumption is violated, the SPML estimates are very sensitive to the model mis-specification and contain considerable bias. As SPML is more sensitive to the underlying disease model than is WEE, its performance under convenient samples may be worse than WEE even for linear logistic disease model. Its performance under stratified samples are comparable to random sample, as similar to WEE, SPML does not use sampling weights which might dominate the estimates.
Type I error estimates and power comparisons
In this section, we further investigate the type I error and power of WEE approach with bootstrap procedure, and compare it with IPW and SPML for the primary hypothesis H 0 : β 1 = 0. For type I error comparisons, we consider the association between a binary Y and a single pre-selected SNP with no covariates under random samples. The MAF of the SNP ranges from 10% to 50%, and the primary disease models follows Logistic, Interaction or Piecewise settings. We simulate 100,000 Monte-Carlo samples with 2,000 cases and 2,000 controls. ranges between 0.14 and 0.33 as a result. The power at significance level α = 0.05 for 1,000 MonteCarlo samples with 2,000 cases and 2,000 controls using the random and stratified sampling schemes are presented in Table  4 . Under random samples, WEE and IPW demonstrate similar power regardless of the underlying disease models. The SPML is also more powerful for detecting the X − Y associations when the underlying disease model P(D|X, Y) is linear logistic, but its type I error blows up when the underlying models do not satisfy its linear logistic assumption. Under stratified sampling scheme, where subjects with large sampling weights may dominate the estimates in IPW, WEE proves far more powerful than IPW.
The performance under biased estimated P(D|X, Z)
The proposed estimates made two assumptions in the estimation of P(D|X, Z) that the primary disease prevalence is known as P 0 and the estimated P(D|X, Z) follows a linear logistic model as follows:
The Table 1 The relative bias (RB), standard error (SE) and mean squared error (MSE) of the estimated coefficient β 1 under simple sampling scheme. The true value β * 1 = 0.2. "LogR" stands for logistic regression. "LR" stands for linear regression. "Case" stands for unadjusted regression using case sample only. "Control" stands for unadjusted regression using control sample only. "CC" stands for unadjusted regression using both case and control samples. "Adj CC" stands for regression using both case and control samples adjusting for primary disease status. "IPW" stands for inverse probability weighting regression. "SPML" stands for semi-parametric maximum likelihood regression. "WEE (T)" stands for the proposed weighted estimating equation (WEE) approach estimated by generating pseudo counter-factual observations with T replicates. "WEE" stands for the proposed weighted estimating equation (WEE) approach estimated by solving its conditional expectation. Note: * The power is not given due to the inflated type I error.
"WEE (T)" stands for the proposed weighted estimating equation (WEE) approach estimated by generating pseudo counter-factual observations with T replicates. "WEE" stands for the proposed weighted estimating equation (WEE) approach estimated by solving its conditional expectation.
Logistic
Table 4
Power of WEE approach in comparison with IPW and SPML under random samples and stratified samples (α = 0.05). "IPW" stands for inverse probability weighting logistic regression. "SPML" stands for semi-parametric maximum likelihood based logistic regression. "WEE" stands for the proposed weighted estimating equation (WEE) approach estimated by generating pseudo counter-factual observations with T = 10 replicates.
assumption. In this section, we further investigate the robustness of our proposed method when the P 0 is incorrectly estimated. The disease prevalence is often estimated from cohort studies or literature and can also be biased. Instead of using the true disease prevalence generated P 0 = 10%, we assume that we obtain the mis-specified P 0 value ranging from 5% to 20% for estimation under the Logistic setting. Table 5 shows the relative bias, standard error and mean squared error of the estimated coefficients from 500 Monte-Carlo replicates with various P 0 values used for estimation. We find that while the estimation bias does increase slowly when the deviation from the true prevalence increases, that even doubling the disease prevalence incurs the biases of less than 7%. We conclude that the resulting estimates are fairly robust against the mis-specified prevalence.
Real Data Analysis
In this section, we apply the proposed WEE approach to an asthma case-control GWAS from the New York University Bellevue Asthma Registry (NYUBAR) (Liu et al. 2011) . The study consisted of 387 asthmatics and 212 healthy controls, genotyped 10 tag SNPs at the Thymic stromal lymphopoietin (TSLP) gene, and identified the association between the TSLP gene and asthma in their primary analysis. In order to do so, the study controlled for a number of demographic and clinical variables such as age, gender, race, smoking status, BMI, FEV 1 and IgE level. As an ongoing non-NIH funded study, the asthma cohort data is not currently available to the public. To illustrate the proposed approach, we consider two secondary phenotypes: one is a binary secondary phenotype of overweight status, and the other is a continuous secondary phenotype of serum Immunoglobulin E (IgE) levels. Overweight is defined as the body mass index greater than 25. A meta-analysis by Flaherman and Rutherford (2006) combining 402 studies between 1966 to October 2004 found that the effect of high body weight during middle childhood showed a 50% increase in relative risk (RR 1.5, 95% CI: 1.2 to 1.8) of having subsequent asthma. The NYUBAR dataset is consistent with their findings with an odds ratio (OR) of having asthma for overweight observations of 1.66 (p-value=0.006; 95% CI: 1.15 to 2.38) compared to the normal counterparts. As a result, the commonly-used classical secondary analysis methods may provide biased estimation. We sought to apply more appropriate approaches for estimation.
IgE is a class of antibody that mediates the immune responses in the pathogenesis of allergic asthma (Burrows et al. 1989 ). An allergen-specific IgE level >0.35 kilo-international units (kIU)/L is considered positive. Elevated IgE is associated with many allergic diseases, such as allergic rhinitis, peanut allergy, latex sensitivity, atopic dermatitis and chronic urticaria (Morjaria and Polosa 2009 ). The secondary analysis of IgE leads to better understanding of the mechanism by which TSLP influences risk to asthma and other allergic diseases. As serum IgE level is approximately normally distributed among cases and controls after log transformation, we first apply linear regression for estimation. In addition, as elevated IgE level instead of mean IgE level plays an essential role in allergic diseases, we also consider the quantile regression approach to further investigate the genetic association with upper quantiles of the log serum IgE levels. Given that the log serum IgE level is strongly associated with asthma in the dataset (OR=1.4; p-value=6.7E-9; 95% CI: 1.26 to 1.58), the commonly-used methods may also provide biased estimates of the association between TSLP gene and log serum IgE level, and we analyze them with novel approaches.
Logistic regression for overweight status
We denote D = {0, 1} as the primary case-control status of asthma, X = {0, 1, 2} as the minor allele count for each of the 10 TSLP SNPs, Y = {0, 1} as the binary secondary trait of whether a person is overweight, and Z as a continuous variable of the propensity score (Guo and Fraser 2010) derived from a set of covariates including age, gender, smoking status, FEV 1 and the first principal component score from 213 ancestry informative markers (Pritchard et al. 2000) . Then the logistic model we consider is as follows
.
Three approaches are used to estimate the coefficient β 1 : IPW, SPML, and WEE. For this regression and for the mean and quantile regressions in later sections, we calculate the overall asthma prevalence as 10.1% based on 6 birth cohort studies, and this information is used to approximate selection probability in IPW, and estimate P(D|X, Y, Z) in SPML and P(D|X, Z) in WEE. The population distribution of F XZ is unknown and the weight P(D|X, Z) is estimated through the sample version equation (equation (13)). The standard errors and p-values were calculated using bootstrap, i.e. we bootstrap cases and controls separately, and re-apply the entire estimating procedure to the bootstrap case-control sample.
The resulting estimated coefficients of the 10 tag SNPs in TSLP gene and overweight are summarized in Table 6 . Before adjusting for multiple comparisons, both IPW and WEE are able to identify two SNPs (rs2289276 and rs11466741) at the a α-level 0.05, while SPML fails to detect any SNPs. The point estimates of WEE and IPW are comparable, but the standard errors of the WEE are smaller resulting in smaller p-values. Specifically, the p-values of SNP rs11466741 are 0.008 and 0.047 in WEE and IPW, respectively.
SPML generates very different estimates from IPW and WEE at many SNPs. As we mentioned in the introduction, IPW is widely known as a robust approach and SPML is efficient but potentially biased with mis-specified P(D|X, Y, Z). Therefore, we further tested the X − Y interactions in P(D|X, Y, Z) to understand the underlying models, and some of the interactive effects are significant (SNPs rs2289278 and rs10035870). Therefore, we believe that the SPML approach contains substantively biases due to the violation of the model assumptions, and WEE as well as IPW provide relative unbiased estimations.
In summary, this work demonstrated that WEE approach combines the advantages of IPW and SPML estimators in that it is robust and fairly efficient in estimating the marker-secondary trait associations.
Mean regression for serum IgE level
In this example, we let Y denote a continuous secondary trait of the log serum IgE level. As in the case before, D is the casecontrol status of asthma, X is the minor allele count for each of the 10 TSLP SNPs, Z is the propensity score of the covariates. We then consider the IPW, SPML and WEE approaches under the following linear regression:
The resulting estimated coefficients are summarized in Table 7. WEE identifies three SNPs (rs11466741, rs11466743 and rs10035870) at a α-level of 0.05 before adjusting multiple comparison, IPW detects one significant SNP rs10035870, and SPML fails Table 5 The sensitivity of the WEE approach to the mis-specifying primary disease prevalence P 0 . P 0 = 10% is the true disease prevalence. Table 6 Estimated mean allelic effects on overweight status in logistic regression. "IPW" stands for inverse probability weighting logistic regression. "SPML" stands for semi-parametric maximum likelihood logistic regression. "WEE" stands for the proposed weighted estimating equation (WEE) approach estimated by simulating pseudo observations. to detect any SNP. As in the logistic regression for the overweight status, the point estimates of WEE and IPW are comparable, and WEE is able to detect more SNPs because it is more efficient than IPW. SPML not only provides biased estimates due to the violation of its assumption on P(D|X, Y, Z), but also fails to improve the efficiency in comparison with WEE. WEE provides the most robust and efficient estimation of the associations between TSLP gene and serum IgE level.
SNP
Quantile regression for serum IgE level
Elevated serum IgE levels instead of the mean serum IgE levels contribute to the allergic effects. Therefore, we also consider quantile regression for the secondary analysis to identify the TSLP variants that are associated with the upper quantiles of the serum IgE level. In addition, we use quantile regression to deepen our knowledge from mean regression on how SNPs affect the location, scale and distribution of serum IgE levels. The quantile model we consider is as follows:
where the X is the minor allele count for each of the 10 TSLP SNPs, Z is a continuous variable of propensity score developed from covariates, and Y is the log serum IgE level. To evaluate the effects of the TSLP gene variants on different levels of IgE, we estimate the model at quantile levels of 0.15, 0.25, 0.5, 0.75 and 0.85, respectively. Two approaches are used to estimate the coefficient β 1 , IPW and WEE, as the SPML approach is likelihood based and cannot be apply to non-parametric regressions. The resulting estimated quantile coefficients are summarized in Table 8 . The estimated quantile coefficients from the two approaches are comparable. However, the bootstrap standard errors of the IPW estimates are much bigger than the ones from WEE. Consequently, the WEE estimates are more powerful in detecting the quantile associations.
For the three SNPs that are significant in mean regression in Table 7 , their results from quantile regressions also indicate significant associations, and these associations remain significant even after a conservative Bonferroni correction for estimating different quantile levels and the number of SNPs. Moreover, quantile regression is able to detect the SNPs that are associated only with upper quantile but not the mean of serum IgE level. Specifically, WEE shows that SNPs rs2289276, rs2289278, rs2289277 and rs11466750 have significant association with 75th quantile of log serum IgE level; however, the mean regression did not indicate significant associations, illustrating the potential for the new approach to discover new associations.
Quantile analysis is able to present a comprehensive picture on the effects of the SNPs on the entire distribution of serum IgE level. To obtain a more complete picture, we estimate the quantile coefficients on a fine grid of quantile levels. In Figures  1(a) and 1(b) , we plotted the estimated conditional distribution functions with different genotypes at SNPs rs10035870 and rs11466743, respectively. Specifically, the solid curve in Figure  1(a) is the estimated quantile function for the cases with genotype AA at rs10035870, and the dashed line is for the individuals with genotype AG/GG. In Figure 1(b) , the solid curve is the estimated quantile function for genotype GG at rs11466743, and the dashed line for genotype AG/AA. Both SNPs were found to have significant impact on the distribution of serum IgE level. SNP rs10035870 has strong positive effect on the entire distribution of serum IgE level, and thus subjects with the major allele at rs10035870 tend to have higher serum IgE level in general. In contrast, SNP rs11466743 only has strong impact on the median and upper quantiles, but has little effect on the lower quantiles of serum IgE level. As indicated in Figure 1(b) , the subjects with genotype AG/AA in rs11466743 are less likely to have a very high serum IgE level compared to those with genotype GG, however, they also have equal chance to have low IgE serum level.
In summary, the quantile regression approach demonstrates two attractive features in marker-secondary trait analysis. First, it is able to identify additional SNPs that are associated only with certain quantiles of Y. Second, it describes a complete picture of the entire Y distribution where the associations exist. Given these findings it is clear that existing approaches are either inefficient for this type of regressions (IPW) or unable to perform (SPML). The proposed WEE approach can supplement the secondary analysis by facilitating this type of regression.
Discussion
In this paper, we propose a general framework of weighted estimating equation that provides unbiased estimation of the genetic association with secondary phenotypes in case-control designs. It enjoys a number of attractive properties in the following aspects.
First, its framework is flexible to accommodate various types of single secondary phenotypes and regressions. We illustrated WEE using logistic regression for binary outcomes, and linear regression and quantile regression for continuous outcomes in this paper. Moreover, with appropriately selected estimating functions, WEE can be applied to many other types of outcomes, such as ordinal, nominal, count, and time-to-event traits. An example of the application of WEE for survival analysis is provided in this paper's Appendix.
Second, WEE can easily accommodate multiple SNPs and covariates at a time. Although the approach presented for GWAS data focuses primarily on a single SNP and a few common covariates including population substructure, it can be applied to a much wider range of scenarios for the secondary analysis. For example, rare variants can be aggregated the in a region, and WEE can be applied to the aggregated data for the detection of rare variant effects in sequencing studies. It can also be incorporated into high dimensional data analysis such as conducting variable selection from a large number of SNPs and covariates using cross-validation or penalty functions like Lasso.
Third, WEE does not make any assumptions on the Y − D association, which is more general than most likelihood based approaches. As shown in the simulation studies, the WEE yields unbiased X − Y association estimation regardless of the Y − D association.
Fourth, WEE is not sensitive to sampling schemes. Although the IPW approach is a simple and flexible method that works for any models, it requires knowing additional information on sampling probabilities. The resulting estimates may not be robust or efficient under its sampling schemes, such as under the existence of confounding factors and over-weighted observations. Finally, WEE is computationally simple and straightforward. The essence of the new estimating equations is weighted regression. Hence the computation does not require special software or packages. We publish the R functions of WEE approach using linear regression, logistic regression, and quantile regression on github (https://github.com/songxiaoyu/ secondary-analysis-in-case-control-studies) together with selected codes of comparison methods and simulations. Users Table 8 The estimated allelic effects on log serum IgE level in quantile regression at quantile levels of 0.15, 0.25, 0.5, 0.75, and 0.85. "IPW" stands for inverse probability weighting quantile regression. "WEE" stands for the proposed weighted estimating equation (WEE) approach estimated by generating pseudo counter-factual observations with T = 10 replicates.
can use these functions directly for their analyses in R or revise the codes based on their respective needs. Overall, the WEE provides a very general secondary analysis framework. Through intensive numerical investigations, we found that it is particularly useful and outperforms the existing approaches when P(D|X, Y) do not follow a linear logistic model, the sampling scheme is unknown or complex, or likelihood functions are not available.
Based on our investigations on the secondary analysis in the case-control studies, we provide some suggestions for the selection of methods in a real GWAS study. The first step is investigating the Y and D relationship. If Y ⊥ D, classical methods are valid, and researchers do not need to consider novel approaches to adjust for biases. For studies where Y are D are correlated regardless of the source of correlation, it is worthwhile considering the sampling scheme. The IPW approach provides robust and similar efficient estimates to those of the WEE approach under random sample. However, if the sampling scheme is unclear or complex, WEE could serve as an alternative approach. One may need to be cautious with likelihood based approaches such as SPML, as the estimates may be biased and the efficiency may not be achieved with mis-specified underlying disease model.
Future extensions
The WEE approach can be extended in a few directions. First, it can be adapted for studies with more complex designs. For example, we can apply the same idea to matched case-control designs, and combine their estimating functions of the matched subsets for estimation. WEE can also be extended to studies where primary disease includes multiple categories or is continuously but oversampled at the "low" and/or "high" extremes. The conditional primary disease prevalence f (D|X, Z) can be estimated using proportional odds regression or multinomial logistic regression for categorical primary disease and certain parametric likelihoods for continuous primary disease.
Another extension is to consider meta/mega analysis combining WEE estimates from multiple case-control studies. As most of the case-control studies are powered for the primary analysis, the power for detecting the important SNPs of secondary traits using a single data set can be limited. If there exist multiple case-control studies that measure the same secondary trait, combining them could greatly enhance the power. Another way to improve the power is to model multiple correlated secondary traits jointly. If a SNP is associated with multiple traits, analyzing them jointly could improve the detecting power. The WEE approach can also be extended to multivariate regressions by replacing the estimating function S by the generalized estimating functions as in Liang et al. (1992) .
In summary, the construction of WEE is straightforward and computationally efficient by evaluating the expected counterfactual estimating functions or generating pseudo observations. It provides a robust and fairly efficient unbiased estimation for the marker-secondary phenotype association for multiple types of secondary traits. It also has appropriate type I error rate and relative large power, and has proven robust against disease prevalence mis-specification. Finally, WEE can be extended to multiple study designs and can be applied to multiple regressions.
